@article{ref1,
title="State naloxone co-prescribing laws show mixed effects on overdose mortality rates",
journal="Drug science, policy and law",
year="2022",
author="Duska, MaryKate and Rhoads, Jared M. and Saunders, Elizabeth C. and Onega, Tracy",
volume="8",
number="",
pages="e20503245221112575-e20503245221112575",
abstract="OBJECTIVETo examine the relative changes in opioid overdose mortality rates between states that have and have not adopted naloxone co-prescribing laws.<br><br>METHODSWe performed a synthetic control analysis. National Vital Statistics data for the years 2012?2018 were analysed, and five states with naloxone co-prescribing laws were examined: Arizona, Florida, Rhode Island, Vermont, and Virginia. Opioid overdose-related deaths were identified through cause-of-death ICD-10 codes.<br><br>RESULTSOur pooled analysis for all opioid-related deaths showed no significant changes in opioid-related mortality rates in treated states, post naloxone co-prescribing law adoption (?0.05; 95% CI: ?0.43, 0.33). Rates of other and unspecified narcotic-related mortality rates in Rhode Island were found to have decreased post-law adoption (?0.13; 95% CI: ?0.25, ?0.00).<br><br>CONCLUSIONSThese findings suggest that naloxone co-prescribing laws were not associated with changes to overall opioid overdose mortality rates, post-law adoption, during the study period. However, Rhode Island did see a decrease in other and unspecified narcotic-related mortality rates post-law adoption. This is perhaps due to the comprehensive nature of the state's law. As overall rates of naloxone co-prescribing remain low, interventions to enhance naloxone prescribing and distribution may be necessary for co-prescribing laws to impact opioid-related mortality rates.<p /> <p>Language: en</p>",
language="en",
issn="2050-3245",
doi="10.1177/20503245221112575",
url="http://dx.doi.org/10.1177/20503245221112575"
}